Author/Authors :
Tayeri, Katayoon Isfahan Triangular Clinic - Isfahan University of Medical Sciences, Isfahan , Radfar, Ramin Isfahan Triangular Clinic - Isfahan University of Medical Sciences, Isfahan , Yaran, Majid Infectious Diseases and Tropical Medicine Research Center - Isfahan University of Medical Sciences, Isfahan , Kassaian, Nazila Infectious Diseases and Tropical Medicine Research Center - Isfahan University of Medical Sciences, Isfahan , Nokhodian, Zary Infectious Diseases and Tropical Medicine Research Center - Isfahan University of Medical Sciences, Isfahan , Ataei, Behrooz Infectious Diseases and Tropical Medicine Research Center - Isfahan University of Medical Sciences, Isfahan , Fadaei, Reza Isfahan Triangular Clinic - Isfahan University of Medical Sciences, Isfahan
Abstract :
Hepatitis C virus (HCV) has been recognized
as a major health problem worldwide. The
estimated number of infected individuals is over 170
million people worldwide (1). After hepatitis B, it is the
most important cause of chronic hepatitis, cirrhosis
and hepatocellular carcinoma. Therefore, prevention
of HCV infection is one of the most important
public health concerns, because the majority of
infected people would experience chronic hepatitis
(2, 3). HCV can be easily transmitted through blood
products transfusion and infected syringes. No
surprise, the infection rate is remarkably high among
injecting drug abusers (IDUs) (4, 5).
Keywords :
C Virus , (HCV) , hepatitis B , infection
